Open
Actively Recruiting
A long-term study to further evaluate the risk of hepatotoxicity associated with TURALIO™ (pexidartinib) treatment
About
Brief Summary
This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.
- If you need assistance with ClinicalTrials.gov registration for an oncology study, please contact the Jonsson Comprehensive Cancer Center's Office of Regulatory Compliance.
- If you need assistance with ClinicalTrials.gov registration for a non-oncology study, please contact the Office of Regulatory Affairs.
Phase
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
21-000498
Category
Kidney Cancer
Principal Investigator
Location
- UCLA Santa Monica
- UCLA Westwood